Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Leases (2016 - 2018)

Wave Life Sciences (WVE) has disclosed Capital Leases for 4 consecutive years, with $9.2 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Capital Leases rose 198.87% year-over-year to $9.2 million, compared with a TTM value of $9.2 million through Dec 2018, up 198.87%, and an annual FY2018 reading of $9.2 million, up 198.87% over the prior year.
  • Capital Leases was $9.2 million for Q4 2018 at Wave Life Sciences, up from $8.2 million in the prior quarter.
  • Across five years, Capital Leases topped out at $9.2 million in Q4 2018 and bottomed at $31000.0 in Q3 2016.
  • Average Capital Leases over 4 years is $2.6 million, with a median of $1.6 million recorded in 2017.
  • The sharpest move saw Capital Leases plummeted 67.02% in 2016, then surged 6651.61% in 2017.
  • Year by year, Capital Leases stood at $78000.0 in 2015, then surged by 48.72% to $116000.0 in 2016, then soared by 2567.24% to $3.1 million in 2017, then surged by 198.87% to $9.2 million in 2018.
  • Business Quant data shows Capital Leases for WVE at $9.2 million in Q4 2018, $8.2 million in Q3 2018, and $6.5 million in Q2 2018.